Aptamer 学术简报 — neurodegeneration — 2026-06-22
自动生成 by RBTX Aptamer Tracker v0.1。 子主题 neurodegeneration:近 14 天 3 篇命中(aptamer 池 168 篇)。
评分公式:composite = 0.45×log(IF) + 0.35×log(cites_velocity) + 0.10×social + 0.10×recency_bonus;满分 100。
#1 [8.3] Novel aptamers targeting heparan sulfate for delivery of RNA therapeutics in Alzheimer's disease.
- Journal: Progress in biomedical engineering (Bristol, England) (IF ?)
- Date: 2026-06-17 · Citations: 0
- Authors: Mehmood A, Shah AZ, Martinez Juarez JA et al. (6 authors)
- DOI: 10.1088/2516-1091/ae7eb9 · PMID: 42309126
- Score components: recency 83.3
Heparan sulfate (HS) proteoglycans are abundant, sulfation-patterned glycosaminoglycans on brain cells and the neurovascular unit that interact with amyloid-β (Aβ) and tau, aggregate and propagate proteopathic species, and modulate cellular uptake pathways. Aptamers are short, chemically synthesized single-stranded nucleic acids that fold to for...
#2 [8.0] Characterization of the plasma proteomic profile of dual trajectories in cognitive status and physical performance.
- Journal: GeroScience (IF ?)
- Date: 2026-06-16 · Citations: 0
- Authors: Rathbun AM, Chen C, Tian Q et al. (6 authors)
- DOI: 10.1007/s11357-026-02356-y · PMID: 42301613
- Score components: recency 80.0
Dual declines in cognitive status and physical performance increase dementia risk but shared biological mechanisms between processes remain unclear. We investigated plasma proteomic signatures underlying dual decline in older adults from the Invecchiare in Chianti cohort (n = 774; age ≥ 60). Group-based trajectory models with up to 15 years of d...
Methodology
- 数据源:PubMed (esearch + esummary), OpenAlex (concept C2776201186 + DOI 反查 citations), bioRxiv (preprints)
- 去重:按 DOI 跨源合并
- IF:硬编码 top 50 期刊 JCR 2024 IF(
config.JOURNAL_IF) - Citation velocity:OpenAlex
cited_by_count/ 发表天数 - Social:Reddit r/science + r/biotech + HN(DOI/title 关键词搜)
- 窗口:近 14 天发表;超出 30 天 recency_bonus = 0
- 每天:建议 8-9am 跑
python run.py collect && python run.py score && python run.py report